StockData
Corcept Therapeutics Inc logo

Corcept Therapeutics Inc (CORT) stock

CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30537% above fair value
$70.07+0.85 (+1.23%)

Close on Nov 17, 2026Market cap $7.57BP/E 166.8Yield –

Corcept Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Corcept Therapeutics's price to book ratio was 12.2× on Nov 11, 2026, against 15.0× a year earlier. Over the last 5 years it ranged from 4.4× to 20.8×, with a median of 7.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.2×+5.6
2025Dec 31, 20256.6×−2.2
2024Dec 31, 20248.8×+0.8
2023Dec 29, 20238.0×+2.9
2022Dec 30, 20225.0×+0.4
2021Dec 31, 20214.7×−1.9
2020Dec 31, 20206.6×+2.1
2019Dec 31, 20194.5×−2.1
2018Dec 31, 20186.6×−17.3
2017Dec 29, 201723.9×−1.9
2016Dec 30, 201625.8×−14.4
2015Dec 31, 201540.2×−55.0
2014Oct 31, 201495.2×+84.8
2013Dec 31, 201310.4×+8.6
2012Dec 31, 20121.8×−10.4
2011Jul 29, 201112.2×–

More Corcept Therapeutics figures

See a number that looks wrong?